Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04939272
Title Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Recruitment Recruiting
Gender
Phase Phase Ib/II
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

mantle cell lymphoma

Therapies

Copanlisib + Venetoclax

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.